Delivery Order SPE2DR25D3201-SPE2DR26FT5LY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20 units, with a ceiling value of $3,332.36 and an ultimate completion date of January 8, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,220.22 to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100 count). This non-competitive, firm fixed-price delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2026. The award represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $2,107.38 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (20 units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 27, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the company's role as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100 count) with a ceiling value of $1,838.12. This competitive delivery order utilizes firm fixed-price terms and is scheduled for completion by March 12, 2025. The contract does not carry a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $7,435.00 for the supply of Amoxicillin 500 mg tablets (100 count). This competitively awarded, non-set-aside contract is classified as a firm fixed-price delivery order with a completion date of December 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.59 to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100-count) with a completion date of January 9, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a $2,092.43 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This competitively awarded, firm fixed-price delivery order is set to be completed by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement typical of routine medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,056.72 to AmerisourceBergen Drug Corp for Amoxicillin-Clavulanate 875-125 mg tablets (100 count) on August 14, 2025, with a completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,146.95 to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100 count). This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 18, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services under...
- The Defense Logistics Agency awarded a $1,981.11 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This firm fixed-price contract, which must be completed by July 30, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5LYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Amoxicillin 875 mg tablets in quantities of 100 units. This firm fixed-price contract, valued at $1,020.36, represents a non-competitive delivery order with an ultimate completion date of January 16, 2026. The award was issued under a competitive basis with no set-aside designation. Performance will be executed from the company's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031. This IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling task orders for a broad range of prescription medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The underlying IDC structure allows DLA to efficiently procure essential pharmaceutical commodities required by military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/14/26 |